Department of Tumor Biology and Pathology, Pathology Unit, Centre Georges-Francois Leclerc, Dijon, Bourgogne, France
Department of Clinical Oncology, Centre Georges-Francois Leclerc, Dijon, Bourgogne, France.
J Clin Pathol. 2020 Sep;73(9):597-601. doi: 10.1136/jclinpath-2019-205783. Epub 2020 Jan 24.
Metaplastic breast carcinoma is a rare subtype of breast cancer. This subtype is mostly found in association with poorly differentiated ductal breast carcinomas and rarely with other breast carcinoma types. We report the case of a 69-year-old woman with an exceptional invasive lobular breast carcinoma associated with metaplastic squamous cell bone metastasis occurring 2 years after the initial breast cancer diagnosis. Whole-exome sequencing and subsequent immunohistochemistry of the lesions were used to link the squamous cell bone metastasis of unknown origin to the primary breast carcinoma initially diagnosed. Searching for primary carcinoma when metastatic lesions of unknown origin occur can be complex. Current molecular biology techniques may help pathologists in associating metastasis with the primary carcinoma by identifying shared specific gene mutations, even when different morphological and immunohistochemical profiles are observed between the tumours.
化生性乳腺癌是一种罕见的乳腺癌亚型。这种亚型主要与低分化导管乳腺癌相关,很少与其他乳腺癌类型相关。我们报告了一例 69 岁女性的病例,她患有特殊的浸润性小叶乳腺癌,伴化生性鳞状细胞骨转移,该转移发生在初始乳腺癌诊断后 2 年。对病变进行全外显子组测序和随后的免疫组织化学分析,将来源不明的鳞状细胞骨转移与最初诊断的原发性乳腺癌联系起来。当发生来源不明的转移灶时,寻找原发性癌可能很复杂。目前的分子生物学技术可以通过识别共享的特定基因突变,帮助病理学家将转移与原发性癌联系起来,即使在肿瘤之间观察到不同的形态和免疫组织化学特征时也是如此。